Other
Pulse field ablation
Pulse field ablation is an intervention with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
100%(1 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Active, not recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
active_not_recruiting267%
completed133%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingnot_applicable
Electroporation for Treatment of Atrial Fibrillation
NCT06134752
active_not_recruitingnot_applicable
Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation
NCT05940597
completednot_applicable
Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System
NCT05293639
Clinical Trials (3)
Showing 3 of 3 trials
NCT06134752Not Applicable
Electroporation for Treatment of Atrial Fibrillation
NCT05940597Not Applicable
Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation
NCT05293639Not Applicable
Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3